MAR 20, 2014 10:00 AM PDT

Neuroeconomy; Economic Impact of Neurodegenerative Diseases both in the US and Globally

Presented At Neuroscience
Speakers
  • Founder and CEO, Think Interfaces, Inc.
    Biography
      Dr. Morrow earned a doctorate degree in cognitive neuroscience from La Sapienza University in Rome, Italy, and went on to train at Mount Sinai Hospital in New York City at the invitation of professor Melvin Yahr. While working at the neurology department of Mount Sinai, she conducted studies using EEG-based brain mapping techniques with Parkinsons patients. Afterwards she received further education and training in Clinical Neuropsychology under Dr. Yaakov Stern at Columbia Presbyterian Hospital in New York City. As a Clinical Neuropsychologist, she has over 20 years experience assessing and treating adults and children with various learning and neurological issues, specializing in the treatment of learning disabilities, attention deficit disorder and the differential diagnosis of complex brain disorders. As a neuroscientist, she used visual evoked potentials and other neuroimaging modalities to study brain functioning, completing successful research collaborations with major universities in Europe and the United States. Most recently, Dr. Morrow developed a dry electrode wireless EEG headset and brain-computer interface that incorporates advancements from different branches of science and technology. Dr. Morrows vision is to help improve the quality of life for children and adults using simple, non-invasive systems. One of her companies, THINK Interfaces, Inc., was created to provide patients with non-invasive, non-pharmacological methods for the diagnosis and remediation of patients with ADD/ADHD, Parkinsons Disease, Alzheimers Disease, and age-related cognitive capacity, memory and focus deficits. Her system is currently in clinical trials on children with ADD/ADHD. Dr. Morrow collaborates with top scientists and engineers from leading universities around the world with the aim of conducting multidisciplinary clinical research and the development of hardware and software products for the purpose of delivering tangible benefits to millions around the globe.

    Abstract:

    When speaking of neurodegenerative diseases, average public is not made aware of the true cost that brain related disorders have on annual budget. The true impact on economy is not usually the direct cost of healthcare, but rather, loss of daily productivity, of not only the primary person affected, but also of the caretakers and family. Primary caretaker functions like a manager for the case. He or she loses days of work because of caretakers needs and involvement. Secondary impact on the case is anxiety and depression ensuing the illness, not only present in the primary patient, but also in family members. This further decreases productivity on the global scale. Thomas Insel, the director of NIMH suggested three approaches to estimate global economic burden: (a) a standard cost of illness method, (b) macroeconomic simulation, and (c) the value of a statistical life. The results of all three methods project staggering costs over the next two decades, with cardiovascular disease, chronic respiratory disease, cancer, diabetes, and mental health representing a cumulative output loss of $47 Trillions, roughly 75% of the global GDP in 2010. Over 2 billion people suffer from brain-based related productivity loss, which translates into a 2 trillion economic burden. One approach is to find innovative ways to prevent and treat diseases in a more economically feasible ways: neurotechnology and biotechnology of healthcare.


    Show Resources
    You May Also Like
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    APR 27, 2018 10:00 AM PDT
    C.E. CREDITS
    APR 27, 2018 10:00 AM PDT
    DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
    AUG 15, 2018 08:00 AM PDT
    C.E. CREDITS
    AUG 15, 2018 08:00 AM PDT
    DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
    JUN 26, 2018 06:00 AM PDT
    C.E. CREDITS
    JUN 26, 2018 06:00 AM PDT
    Date: June 26, 2018Time: 6:00 a.m. PDT, 9:00 a.m. EDT, 1500 CEST Today’s hematology analyzers employ various methods for enumerating platelets. These methods include: e...
    Loading Comments...
    Show Resources